首页> 外文OA文献 >Erratum to: The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases

【2h】

Erratum to: The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases

机译：错误到：目前的状态和JAK2抑制剂的未来治疗髓原疾病

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yasumichi Hitoshi; Nan Lin; Donald G. Payan; Vadim Markovtsov;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Erratum to: The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases [J] . Yasumichi Hitoshi, Nan Lin, Donald G. Payan, International Journal of Hematology . 2010,第3期

机译：勘误：用于治疗骨髓增生性疾病的JAK2抑制剂的现状和未来
2. The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases. [J] . Hitoshi Y, Lin N, Payan DG, International journal of hematology . 2010,第2期

机译：JAK2抑制剂在骨髓增生性疾病治疗中的现状和未来。
3. The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases [J] . Yasumichi Hitoshi, Nan Lin, Donald G. Payan, International Journal of Hematology . 2010,第2期

机译：JAK2抑制剂在治疗骨髓增生性疾病中的研究现状与未来
4. Study in occurrence of Dutch elm disease, current status and the future of disease in Iran [C] . Kamran Rahnama, Gh.Asadeh, M.Salahshour Asian conference on plant pathology . 2000

机译：荷兰榆树病，现状与伊朗疾病的发生研究
5. Transcriptional and Proteomic Changes Associated with the Sensitivity and Resistance to JAK2 Inhibitors: Implications for the Treatment of BCR-ABL (-) Myeloproliferative Neoplasms (MPNs). [D] . McDevitt, Theresa Marie. 2012

机译：与JAK2抑制剂的敏感性和抗性相关的转录和蛋白质组学变化：对BCR-ABL（-）骨髓增生性肿瘤（MPNs）的治疗意义。
6. Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age hydroxyurea administration disease type and JAK2 mutational status [O] . B Kubesova, S Pavlova, J Malcikova, -1

机译：骨髓增生性肿瘤慢性期的低负荷TP53突变：与年龄羟基脲给药疾病类型和JAK2突变状态的关联
7. Treatment options for hydroxyurea-refractory disease complications in myeloproliferative neoplasms: JAK2 inhibitors, radiotherapy, splenectomy and transjugular intrahepatic portosystemic shunt [O] . Elena Mishchenko, Ayalew Tefferi 2010

机译：野生脲 - 难治性疾病的治疗方案在野生鳞状肿瘤中的并发症：JAK2抑制剂，放疗，脾切除术和外节内肝内口腔分流器
8. Zinc and Diarrheal Disease: Current Status and Future Perspectives [R] . Scrimgeour, A. G., Lukaski, H. C. 2008

机译：锌和腹泻病：现状和未来前景

Erratum to: The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases

著录项

引文网络

相似文献

相关主题

期刊订阅